From Ontogeny to Oncology: Future-Proofing T Cells that Escape

Immune Escape

Nicholas Restifo, MD
Chief Medical Officer, Medici Therapeutics,

David Geffen School of Medicine at UCLA

Contact – jcccevents@mednet.ucla.edu

Website – https://www.uclahealth.org/cancer/news-events/events-calendar

23-105 CHS